Yage Ding

Title: Yage Ding: Innovator in Gene Expression Control

Introduction

Yage Ding is a prominent inventor based in Allston, MA (US). He has made significant contributions to the field of gene expression control, holding 2 patents that showcase his innovative work. His research focuses on developing advanced polypeptide systems that can be inducibly and repressibly controlled.

Latest Patents

Yage Ding's latest patents include "Repressible control of gene expression" and "Inducible control of gene expression." The technology described in these patents is directed towards inducible and repressible polypeptides and polypeptide systems. Specifically, these patents detail split sequence-specific nucleases and split recombinases linked to drug-inducible or drug-repressible dimerization domains. In various embodiments, the polypeptides include sequestering domains and have their expression regulated by an inducible promoter. The patents also cover polynucleotides, vectors, cells, and pharmaceutical compositions that incorporate these polypeptides or polypeptide systems. Furthermore, methods for using these systems to modulate the expression of target polypeptides or to treat subjects in need of cell therapy are also described.

Career Highlights

Yage Ding is affiliated with Boston University, where he continues to advance his research in gene expression technologies. His work has garnered attention for its potential applications in therapeutic settings, particularly in cell therapy.

Collaborations

Yage Ding collaborates with Wilson Wai Chun Wong, contributing to the innovative research environment at Boston University.

Conclusion

Yage Ding's contributions to the field of gene expression control through his patents and research at Boston University highlight his role as a leading inventor in biotechnology. His work has the potential to significantly impact therapeutic approaches in medicine.